Armata Pharmaceuticals Stock Rises on FDA Breakthrough Designation

3-line summary

• Armata Pharmaceuticals shares rose after the company received an FDA breakthrough therapy designation, according to Investing.com.

This summary is our own processing of the source article; see the source link below for full context.